Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
5.46M
-
Shares change
-
+4.25M
-
Total reported value, excl. options
-
$12M
-
Value change
-
+$9.17M
-
Put/Call ratio
-
0.97
-
Number of buys
-
24
-
Number of sells
-
-7
-
Price
-
$2.19
Significant Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) as of Q4 2020
39 filings reported holding HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.46M shares
of 11.8M outstanding shares and own 46.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.73M shares), BlackRock Inc. (1.19M shares), AIGH Capital Management LLC (923K shares), RENAISSANCE TECHNOLOGIES LLC (329K shares), Worth Venture Partners, LLC (234K shares), GEODE CAPITAL MANAGEMENT, LLC (203K shares), PERKINS CAPITAL MANAGEMENT INC (150K shares), Squarepoint Ops LLC (112K shares), Schonfeld Strategic Advisors LLC (95.3K shares), and GSA CAPITAL PARTNERS LLP (89.1K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.